Opzelura 50881-0007-14
Generic: Ruxolitinib
- Manufacturer
- Incyte Corporation
- Dosage Form
- Cream
- Route
- Topical
- Product Type
- Human Prescription Drug
- Marketing Start
- September 21, 2021
- Listing Expires
- December 31, 2026
- Application
- NDA215309
Need to source Opzelura? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ruxolitinib Phosphate | 15 mg/g |
Drug Class
Janus Kinase Inhibitor [EPC]Janus Kinase Inhibitors [MoA]Kinase Inhibitor [EPC]
Selected Package
50881-0007-14Selected1 TUBE in 1 CARTON (50881-007-14) / 3 g in 1 TUBE
Other packages for this product(3)
1 TUBE in 1 CARTON (50881-007-04) / 5 g in 1 TUBE
1 TUBE in 1 CARTON (50881-007-05) / 60 g in 1 TUBE
1 TUBE in 1 CARTON (50881-007-07) / 100 g in 1 TUBE